Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Clinical trial NCT06134362 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06134362
- Sponsor
- ViiV Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-14
- Primary completion
- 2029-03-14
- Enrollment
- 2996
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.